Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of Medicine
Ariva,
PR Newswire SPRING HOUSE, Pa., Aug. 7, 2024 Nipocalimab delayed or prevented severe fetal anemia and 54 percent of study…